SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 31, 17:00
3487.45
61.05 (1.78%)
VOLUME 9,711
LIVE
NSE
Mar 31, 17:00
3488.75
63.45 (1.85%)
VOLUME 280,091
Business News on Dr Reddys Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
See Rs 400cr increase in top line over next few yrs: Hetero 

3.29 pm | 24 Mar 2015 |  Source: CNBC-TV18

The company has 20 facilities across the globe with portfolio of more than 200 products in 138 countries....

Dr Reddy's to launch Hepatitis C drug in India

6.49 pm | 23 Mar 2015 |  Source: PTI

Dr Reddy's Laboratories today entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C d...

Dr Reddy's in talks to buy UCB India business for $135 mn

7.29 pm | 10 Mar 2015 |  Source: Reuters

The talks come as large Indian drugmakers such as Dr Reddy's and Glenmark Pharmaceuticals Ltd seek to bolster their presence in the domestic market, a...

AGs of Texas, California probe DRL's drug pricing mechanism

4.35 pm | 25 Feb 2015 |  Source: PTI

On or about November 10, 2014, DRL received a Civil Investigative Demand (CID) from the Office of the Attorney General, State of Texas requesting cert...

1
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.